Integrated transcriptomic and machine learning analysis reveals novel diagnostic biomarkers for adolescent major depressive disorder.
Source check: Source checked. Not independent scientific confirmation.
Finding: In 15 adolescents with MDD and 15 matched controls, transcriptomic feature selection produced a three-gene diagnostic panel (AUC 0.867); hub-gene expression was additionally examined by RT-qPCR/ELISA. The small single-center sample makes the diagnostic estimate preliminary. The result is reported in Frontiers in Psychiatry. The study does not establish generalization beyond its reported setting or prospective real-world benefit.
Technology: LASSO, SVM-RFE and Random Forest are used to select candidate diagnostic biomarkers from transcriptomic features
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- LASSO, SVM-RFE and Random Forest are used to select candidate diagnostic biomarkers from transcriptomic features
- Test and result
- In 15 adolescents with MDD and 15 matched controls, transcriptomic feature selection produced a three-gene diagnostic panel (AUC 0.867); hub-gene expression was additionally examined by RT-qPCR/ELISA. The small single-center sample makes the diagnostic estimate preliminary.
- Limitation / still unknown
- Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2026.1712225/full · https://doi.org/10.3389/fpsyt.2026.1712225
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.